Table 5.
Model Specifications for ER-GNR and ACR-GNR
| ER-GNR | Coefficient | Standard Error | P |
|---|---|---|---|
| Renal disease | 0.55 | 0.17 | <.001 |
| Ventilated during index hospitalization | 0.71 | 0.18 | <.001 |
| In facility before admission | 0.47 | 0.19 | .015 |
| Carbapenems within 30 d | 0.75 | 0.19 | <.001 |
| Anti-MRSA agents within 30 d | 0.92 | 0.20 | <.001 |
| ACR-GNR | |||
| Male sex | 0.35 | 0.11 | .001 |
| Ventilated during index hospitalization | 0.72 | 0.11 | <.001 |
| In facility before admission | 1.33 | 0.11 | <.001 |
| Carbapenems within 30 d | 0.93 | 0.12 | <.001 |
| Anti-MRSA agents within 30 d | 0.26 | 0.13 | .035 |
Abbreviations: ACR-GNR, antipseudomonal (nonertapenem) carbapenem-resistant Gram-negative rods; ER-GNR, ertapenem-resistant Gram-negative rods; MRSA, methicillin-resistant Staphylococcus aureus.